Preface
Testosterone replacement therapy
Translational Andrology and Urology
2016;
5
(6)
:812-813
.
(18 December 2016)
Original Article
A case series of the safety and efficacy of testosterone replacement therapy in renal failure and kidney transplant patients
Translational Andrology and Urology
2016;
5
(6)
:814-818
.
(18 December 2016)
Improvement of endothelial function following initiation of testosterone replacement therapy
Translational Andrology and Urology
2016;
5
(6)
:819-823
.
(18 December 2016)
Review Article
Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy
Translational Andrology and Urology
2016;
5
(6)
:824-833
.
(18 December 2016)
Pharmacology of testosterone replacement therapy preparations
Translational Andrology and Urology
2016;
5
(6)
:834-843
.
(18 December 2016)
Off label therapies for testosterone replacement
Translational Andrology and Urology
2016;
5
(6)
:844-849
.
(18 December 2016)
Testosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment
Translational Andrology and Urology
2016;
5
(6)
:850-858
.
(18 December 2016)
Testosterone replacement in the infertile man
Translational Andrology and Urology
2016;
5
(6)
:859-865
.
(18 December 2016)
Effects of varicocelectomy on serum testosterone
Translational Andrology and Urology
2016;
5
(6)
:866-876
.
(18 December 2016)
Hormone therapy for transgender patients
Translational Andrology and Urology
2016;
5
(6)
:877-884
.
(18 December 2016)
Hypogonadism and testosterone replacement therapy in end-stage renal disease (ESRD) and transplant patients
Translational Andrology and Urology
2016;
5
(6)
:885-889
.
(18 December 2016)
Testosterone replacement therapy and voiding dysfunction
Translational Andrology and Urology
2016;
5
(6)
:890-897
.
(18 December 2016)
Testosterone replacement therapy and the heart: friend, foe or bystander?
Translational Andrology and Urology
2016;
5
(6)
:898-908
.
(18 December 2016)
Testosterone therapy and prostate cancer
Translational Andrology and Urology
2016;
5
(6)
:909-920
.
(18 December 2016)
Opinion
Impact of recent FDA ruling on testosterone replacement therapy (TRT)
Translational Andrology and Urology
2016;
5
(6)
:921-926
.
(18 December 2016)
Mini-Review
Testicular compartment syndrome: an overview of pathophysiology, etiology, evaluation, and management
Translational Andrology and Urology
2016;
5
(6)
:927-934
.
(18 December 2016)
Guideline
Clinical utility of sperm DNA fragmentation testing: practice recommendations based on clinical scenarios
Translational Andrology and Urology
2016;
5
(6)
:935-950
.
(18 December 2016)
Commentary
Intralesional collagenase clostridium histolyticum study provides real-world analysis
Translational Andrology and Urology
2016;
5
(6)
:951-952
.
(18 December 2016)
Belatacept in renal transplantation—quo vadis?
Translational Andrology and Urology
2016;
5
(6)
:953-955
.
(18 December 2016)
Commentary to low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model, published in J Sex Med 2016;13:22-32 by Li H, Matheu P, Sun F, et al.
Translational Andrology and Urology
2016;
5
(6)
:956-957
.
(18 December 2016)
Invited commentary on GETUG-AFU 16
Translational Andrology and Urology
2016;
5
(6)
:958-960
.
(18 December 2016)
Friend or foe: role of E-cadherin in prostate cancer metastasis
Translational Andrology and Urology
2016;
5
(6)
:961-963
.
(18 December 2016)
Editorial
The luminal-basal paradigm in the urothelial cancer: hope for individualized approach
Translational Andrology and Urology
2016;
5
(6)
:964-965
.
(18 December 2016)
Prostate cancer and hypofractionation: really a new standard of care?
Translational Andrology and Urology
2016;
5
(6)
:966-967
.
(18 December 2016)
Radium-223 and concomitant therapies: prospects and prudence
Translational Andrology and Urology
2016;
5
(6)
:968-970
.
(18 December 2016)
A randomised control trial of salvage radiotherapy and androgen deprivation therapy following prostatectomy: commentary on five year follow-up findings
Translational Andrology and Urology
2016;
5
(6)
:971-973
.
(18 December 2016)
Cabozantinib in advanced renal cell carcinoma: a METEOR impact on clinical practice
Translational Andrology and Urology
2016;
5
(6)
:974-976
.
(18 December 2016)
Low-energy shock wave therapy ameliorates erectile dysfunction in a pelvic neurovascular injuries rat model
Translational Andrology and Urology
2016;
5
(6)
:977-979
.
(18 December 2016)
Liquid biopsies in bladder cancer—did we find the Holy Grail for biomarker analyses?
Translational Andrology and Urology
2016;
5
(6)
:980-983
.
(18 December 2016)
Correspondence
The panoramic view of clear cell renal cell carcinoma metabolism: values of integrated global cancer metabolomics
Translational Andrology and Urology
2016;
5
(6)
:984-986
.
(18 December 2016)
Disclosure:
The focused issue “Testosterone Replacement Therapy” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Daniel A. Shoskes and Lawrence S. Hakim served as the unpaid Guest Editors for the focused issue.
